Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piragliatin Dose Titration in Type 2 Diabetes
NCT00366379Phase 2Completed
- Sponsor
- Roche
- Start
- Jul 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, open-label, single-arm trial of piragliatin in type 2 diabetes mellitus (T2DM), sponsored by Roche. Primary endpoint: Percentage of patients at each dose who achieve FPG <100mg/dL. Started Jul 2006; status: completed.
02
Drugs
piragliatin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00366379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00366379.